Comparison of all-cause mortality associated with non-alcoholic fatty liver disease and metabolic dysfunction-associated fatty liver disease in Taiwan MJ cohort
OBJECTIVES The global burden of non-alcoholic fatty liver disease (NAFLD) is rising. An alternative term, metabolic dysfunction-associated fatty liver disease (MAFLD), instead highlights the associated metabolic risks. This cohort study examined patient classifications under NAFLD and MAFLD criteria...
| Published in: | Epidemiology and Health |
|---|---|
| Main Authors: | Wei-Chun Cheng, Hua-Fen Chen, Hsiu-Chi Cheng, Chung-Yi Li |
| Format: | Article |
| Language: | English |
| Published: |
Korean Society of Epidemiology
2024-01-01
|
| Subjects: | |
| Online Access: | http://www.e-epih.org/upload/pdf/epih-46-e2024024.pdf |
Similar Items
Overlapping group between non‐alcoholic fatty liver disease and metabolic associated fatty liver disease better for liver research
by: Yu‐Ming Cheng, et al.
Published: (2024-10-01)
by: Yu‐Ming Cheng, et al.
Published: (2024-10-01)
Non-alcoholic fatty liver disease associated with greater herpes zoster risk than alcoholic fatty liver disease
by: Cheng-Wei Yu, et al.
Published: (2023-12-01)
by: Cheng-Wei Yu, et al.
Published: (2023-12-01)
Comparison of fatty liver index with fibroscan in non-alcoholic fatty liver disease
by: Marium Ahmed, et al.
Published: (2024-04-01)
by: Marium Ahmed, et al.
Published: (2024-04-01)
Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Index for Classification of Patients with Steatotic Liver Disease
by: Akash Roy, et al.
Published: (2024-09-01)
by: Akash Roy, et al.
Published: (2024-09-01)
Prevalence and clinical outcomes in subtypes of metabolic associated fatty liver disease
by: Kun-Lin Cheng, et al.
Published: (2024-01-01)
by: Kun-Lin Cheng, et al.
Published: (2024-01-01)
Non-alcoholic fatty liver disease: Definition and subtypes
by: Seul Ki Han, et al.
Published: (2023-02-01)
by: Seul Ki Han, et al.
Published: (2023-02-01)
Risk factors and predictors of non-alcoholic fatty liver disease in Taiwan
by: Ying-Chin Lin, et al.
Published: (2011-04-01)
by: Ying-Chin Lin, et al.
Published: (2011-04-01)
Fibrotic Burden in the Liver Differs Across Metabolic Dysfunction-Associated Fatty Liver Disease Subtypes
by: Tae Seop Lim, et al.
Published: (2023-07-01)
by: Tae Seop Lim, et al.
Published: (2023-07-01)
Association of Lipid Profile and Liver Parameters with Different Grades of Non-alcoholic Fatty Liver Disease
by: Drutpal Baghel, et al.
Published: (2023-03-01)
by: Drutpal Baghel, et al.
Published: (2023-03-01)
Evaluation of comorbidity in patients with alcoholic cirrhosis of the liver associated with non-alcoholic fatty liver disease
by: N. R. Matkovska, et al.
Published: (2020-04-01)
by: N. R. Matkovska, et al.
Published: (2020-04-01)
Association between Sarcopenic Obesity Status and Nonalcoholic Fatty Liver Disease and Fibrosis
by: Wolhwa Song, et al.
Published: (2023-01-01)
by: Wolhwa Song, et al.
Published: (2023-01-01)
Changes in indicators of fibrosis in patients with alcoholic liver cirrhosis associated with non-alcoholic fatty liver disease depending on the stage of cirrhosis
by: N. R. Matkovska, et al.
Published: (2020-06-01)
by: N. R. Matkovska, et al.
Published: (2020-06-01)
Assessment of laboratory findings and liver elastography in patients with non-alcoholic fatty liver disease
by: Tarang Taghvaei, et al.
Published: (2023-12-01)
by: Tarang Taghvaei, et al.
Published: (2023-12-01)
The Progression of Liver Fibrosis in Non-alcoholic Fatty Liver Disease
by: Moon Young Kim
Published: (2017-06-01)
by: Moon Young Kim
Published: (2017-06-01)
Correspondence on Letter regarding “Non-alcoholic fatty liver disease: Definition and subtypes”
by: Seul Ki Han, et al.
Published: (2023-07-01)
by: Seul Ki Han, et al.
Published: (2023-07-01)
Draft Clinical Guidelines for the Diagnosis and Treatment of Metabolically Associated Fatty Liver Disease in Children (Non-Alcoholic Fatty Liver Disease)
by: Alexander A. Baranov, et al.
Published: (2025-05-01)
by: Alexander A. Baranov, et al.
Published: (2025-05-01)
Impact of the diagnosis of metabolic dysfunction-associated fatty liver disease and non-alcoholic fatty liver disease in patients undergoing liver transplantation for hepatocellular carcinoma
by: Ji-Qiao Zhu, et al.
Published: (2024-04-01)
by: Ji-Qiao Zhu, et al.
Published: (2024-04-01)
Non-alcoholic fatty liver disease: time for changes
by: T.I. Yefimenko, et al.
Published: (2021-06-01)
by: T.I. Yefimenko, et al.
Published: (2021-06-01)
The association between modified cardiometabolic index with non-alcoholic fatty liver disease and liver fibrosis: a cross-sectional study
by: Yanjun Guo, et al.
Published: (2025-04-01)
by: Yanjun Guo, et al.
Published: (2025-04-01)
Non-Alcoholic Fatty Liver Disease and the Risk of Liver Fibrosis in Chronic Hepatitis B Patients
by: Andri Sanityoso Sulaiman, et al.
Published: (2023-09-01)
by: Andri Sanityoso Sulaiman, et al.
Published: (2023-09-01)
Reactive Oxygen Species as Key Molecules in the Pathogenesis of Alcoholic Fatty Liver Disease and Nonalcoholic Fatty Liver Disease: Future Perspectives
by: Zhiqing Zhang, et al.
Published: (2025-06-01)
by: Zhiqing Zhang, et al.
Published: (2025-06-01)
Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma
by: Byeong Geun Song, et al.
Published: (2023-09-01)
by: Byeong Geun Song, et al.
Published: (2023-09-01)
The Role of the Fatty Liver Index (FLI) in the Management of Non-Alcoholic Fatty Liver Disease: A Systematic Review
by: Teodora Biciusca, et al.
Published: (2023-10-01)
by: Teodora Biciusca, et al.
Published: (2023-10-01)
Research Progress in the Correlation of Non-alcoholic Fatty Liver Disease and Metabolic-associated Fatty Liver Disease with Cardiovascular Diseases in China and Abroad
by: NI Xuetong, WANG Ruoxi, ZHANG Jing, YANG Xinghua
Published: (2024-06-01)
by: NI Xuetong, WANG Ruoxi, ZHANG Jing, YANG Xinghua
Published: (2024-06-01)
Associations between serum clusterin levels and non-alcoholic fatty liver disease
by: Yansu Wang, et al.
Published: (2023-06-01)
by: Yansu Wang, et al.
Published: (2023-06-01)
Clinical Features of Non-Alcoholic Fatty Liver Disease in the Non-Lean Population
by: Min-ran Li, et al.
Published: (2023-05-01)
by: Min-ran Li, et al.
Published: (2023-05-01)
Crosstalk between Lipids and Non-Alcoholic Fatty Liver Disease
by: Divyavani Gowda, et al.
Published: (2023-11-01)
by: Divyavani Gowda, et al.
Published: (2023-11-01)
Prevalence and Profile of Fibrosis in Diabetic Patients with Non-alcoholic Fatty Liver Disease and the Associated Factors
by: Ignatius Bima Prasetya, et al.
Published: (2017-08-01)
by: Ignatius Bima Prasetya, et al.
Published: (2017-08-01)
Prevalence and Profile of Fibrosis in Diabetic Patients with Non-alcoholic Fatty Liver Disease and the Associated Factors
by: Ignatius Bima Prasetya, et al.
Published: (2017-08-01)
by: Ignatius Bima Prasetya, et al.
Published: (2017-08-01)
Pemafibrate Ameliorates Liver Dysfunction and Fatty Liver in Patients with Non-Alcoholic Fatty Liver Disease with Hypertriglyceridemia: A Retrospective Study with the Outcome after a Mid-Term Follow-Up
by: Suguru Ikeda, et al.
Published: (2021-12-01)
by: Suguru Ikeda, et al.
Published: (2021-12-01)
Clinical characteristics of lean metabolic-associated fatty liver disease and the impact of concurrent diabetes mellitus
by: Yu-Ming Cheng, et al.
Published: (2024-09-01)
by: Yu-Ming Cheng, et al.
Published: (2024-09-01)
Adaptation of Clinical Practice Guideline for Assessment of Liver Fibrosis in Patients with Non Alcoholic Fatty Liver Disease in Isfahan Province
by: Sayed Mohammad Hosseeini, et al.
Published: (2024-08-01)
by: Sayed Mohammad Hosseeini, et al.
Published: (2024-08-01)
Update cognition of nonalcoholic fatty liver disease/metabolism‐associated fatty liver disease
by: Weijun Gu, et al.
Published: (2022-03-01)
by: Weijun Gu, et al.
Published: (2022-03-01)
Noninvasive Evaluation of Nonalcoholic Fatty Liver Disease
by: Dae Ho Lee
Published: (2020-06-01)
by: Dae Ho Lee
Published: (2020-06-01)
Diagnostic accuracy of FibroScan-AST (FAST) score, non-alcoholic fatty liver fibrosis score (NFS), FibroScan, and liver fibrosis index (FIB-4) for identifying fibrotic non-alcoholic steatohepatitis in patients with chronic hepatitis B with metabolic dysfunction-associated fatty liver disease
by: Youwen Tan, et al.
Published: (2024-12-01)
by: Youwen Tan, et al.
Published: (2024-12-01)
Clinical characteristics of lean and non-lean non-alcoholic fatty liver disease: a cross-sectional study
by: Mengyan Xu, et al.
Published: (2025-05-01)
by: Mengyan Xu, et al.
Published: (2025-05-01)
The effects of moderate alcohol consumption on non-alcoholic fatty liver disease
by: Hyunwoo Oh, et al.
Published: (2023-02-01)
by: Hyunwoo Oh, et al.
Published: (2023-02-01)
Factors Associated with Liver Fibrosis in Chinese Patients with Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease
by: Luo Y, et al.
Published: (2023-01-01)
by: Luo Y, et al.
Published: (2023-01-01)
Association of Inflammatory Cytokines With Non-Alcoholic Fatty Liver Disease
by: Yamei Duan, et al.
Published: (2022-05-01)
by: Yamei Duan, et al.
Published: (2022-05-01)
Non-Alcoholic Fatty Liver Disease, Atherosclerosis, and Cardiovascular Disease in Asia
by: Yohwan Lim, et al.
Published: (2023-06-01)
by: Yohwan Lim, et al.
Published: (2023-06-01)
Similar Items
-
Overlapping group between non‐alcoholic fatty liver disease and metabolic associated fatty liver disease better for liver research
by: Yu‐Ming Cheng, et al.
Published: (2024-10-01) -
Non-alcoholic fatty liver disease associated with greater herpes zoster risk than alcoholic fatty liver disease
by: Cheng-Wei Yu, et al.
Published: (2023-12-01) -
Comparison of fatty liver index with fibroscan in non-alcoholic fatty liver disease
by: Marium Ahmed, et al.
Published: (2024-04-01) -
Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Index for Classification of Patients with Steatotic Liver Disease
by: Akash Roy, et al.
Published: (2024-09-01) -
Prevalence and clinical outcomes in subtypes of metabolic associated fatty liver disease
by: Kun-Lin Cheng, et al.
Published: (2024-01-01)
